HCV Warning For ESAs Could Raise Questions For Pipeline Drugs
Warning on red cell aplasia and anemia for Procrit and Aranesp in hepatitis C patients could have implications for boceprevir and telaprevir.
Warning on red cell aplasia and anemia for Procrit and Aranesp in hepatitis C patients could have implications for boceprevir and telaprevir.